349 related articles for article (PubMed ID: 11397415)
1. Insights into the toxicokinetics and toxicodynamics of 1,3-butadiene.
Bond JA; Medinsky MA
Chem Biol Interact; 2001 Jun; 135-136():599-614. PubMed ID: 11397415
[TBL] [Abstract][Full Text] [Related]
2. Mutational spectrum of 1,3-butadiene and metabolites 1,2-epoxybutene and 1,2,3,4-diepoxybutane to assess mutagenic mechanisms.
Recio L; Steen AM; Pluta LJ; Meyer KG; Saranko CJ
Chem Biol Interact; 2001 Jun; 135-136():325-41. PubMed ID: 11397399
[TBL] [Abstract][Full Text] [Related]
3. A review of the genetic and related effects of 1,3-butadiene in rodents and humans.
Jackson MA; Stack HF; Rice JM; Waters MD
Mutat Res; 2000 Oct; 463(3):181-213. PubMed ID: 11018742
[TBL] [Abstract][Full Text] [Related]
4. 1,3-butadiene: cancer, mutations, and adducts. Part III: In vivo mutation of the endogenous hprt genes of mice and rats by 1,3-butadiene and its metabolites.
Walker VE; Meng Q
Res Rep Health Eff Inst; 2000 Mar; (92):89-139; discussion 141-9. PubMed ID: 10925840
[TBL] [Abstract][Full Text] [Related]
5. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
[TBL] [Abstract][Full Text] [Related]
6. In vivo doses of butadiene epoxides as estimated from in vitro enzyme kinetics by using cob(I)alamin and measured hemoglobin adducts: an inter-species extrapolation approach.
Motwani HV; Törnqvist M
Toxicol Appl Pharmacol; 2014 Dec; 281(3):276-84. PubMed ID: 25448046
[TBL] [Abstract][Full Text] [Related]
7. 1,3-butadiene: cancer, mutations, and adducts. Part II: Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity.
Recio L; Saranko CJ; Steen AM
Res Rep Health Eff Inst; 2000 Mar; (92):49-87; discussion 141-9. PubMed ID: 10925839
[TBL] [Abstract][Full Text] [Related]
8. Epidemiological and mechanistic data suggest that 1,3-butadiene will not be carcinogenic to humans at exposures likely to be encountered in the environment or workplace.
Bond JA; Recio L; Andjelkovich D
Carcinogenesis; 1995 Feb; 16(2):165-71. PubMed ID: 7859344
[TBL] [Abstract][Full Text] [Related]
9. 1,3-Butadiene: toxicity and carcinogenicity in laboratory animals and in humans.
Melnick RL; Huff J
Rev Environ Contam Toxicol; 1992; 124():111-44. PubMed ID: 1732994
[TBL] [Abstract][Full Text] [Related]
10. 1,3-Butadiene working group report.
Adler ID; Cochrane J; Osterman-Golkar S; Skopek TR; Sorsa M; Vogel E
Mutat Res; 1995 Aug; 330(1-2):101-14. PubMed ID: 7623862
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of 1,3-butadiene: inhalation pharmacokinetics and tissue dosimetry of butadiene epoxides in rats and mice.
Himmelstein MW; Turner MJ; Asgharian B; Bond JA
Toxicology; 1996 Oct; 113(1-3):306-9. PubMed ID: 8901914
[TBL] [Abstract][Full Text] [Related]
12. Molecular dosimetry of N-7 guanine adduct formation in mice and rats exposed to 1,3-butadiene.
Koc H; Tretyakova NY; Walker VE; Henderson RF; Swenberg JA
Chem Res Toxicol; 1999 Jul; 12(7):566-74. PubMed ID: 10409395
[TBL] [Abstract][Full Text] [Related]
13. Cellular and molecular basis for species, sex and tissue differences in 1,3-butadiene metabolism.
Elfarra AA; Krause RJ; Kemper RA
Chem Biol Interact; 2001 Jun; 135-136():239-48. PubMed ID: 11397394
[TBL] [Abstract][Full Text] [Related]
14. Development of a preliminary physiologically based toxicokinetic (PBTK) model for 1,3-butadiene risk assessment.
Sweeney LM; Himmelstein MW; Gargas ML
Chem Biol Interact; 2001 Jun; 135-136():303-22. PubMed ID: 11397398
[TBL] [Abstract][Full Text] [Related]
15. Differences in butadiene adduct formation between rats and mice not due to selective inhibition of CYP2E1 by butadiene metabolites.
Pianalto KM; Hartman JH; Boysen G; Miller GP
Toxicol Lett; 2013 Nov; 223(2):221-7. PubMed ID: 24021170
[TBL] [Abstract][Full Text] [Related]
16. Genetic effects of 1,3-butadiene and associated risk for heritable damage.
Pacchierotti F; Adler ID; Anderson D; Brinkworth M; Demopoulos NA; Lähdetie J; Osterman-Golkar S; Peltonen K; Russo A; Tates A; Waters R
Mutat Res; 1998 Jan; 397(1):93-115. PubMed ID: 9463556
[TBL] [Abstract][Full Text] [Related]
17. 1,3-Butadiene: II. Genotoxicity profile.
Albertini RJ; Carson ML; Kirman CR; Gargas ML
Crit Rev Toxicol; 2010 Oct; 40 Suppl 1():12-73. PubMed ID: 20868267
[TBL] [Abstract][Full Text] [Related]
18. Cob(I)alamin for trapping butadiene epoxides in metabolism with rat S9 and for determining associated kinetic parameters.
Motwani HV; Fred C; Haglund J; Golding BT; Törnqvist M
Chem Res Toxicol; 2009 Sep; 22(9):1509-16. PubMed ID: 19764821
[TBL] [Abstract][Full Text] [Related]
19. Comparison of blood concentrations of 1,3-butadiene and butadiene epoxides in mice and rats exposed to 1,3-butadiene by inhalation.
Himmelstein MW; Turner MJ; Asgharian B; Bond JA
Carcinogenesis; 1994 Aug; 15(8):1479-86. PubMed ID: 8055623
[TBL] [Abstract][Full Text] [Related]
20. Exposure-response of 1,2:3,4-diepoxybutane-specific N-terminal valine adducts in mice and rats after inhalation exposure to 1,3-butadiene.
Georgieva NI; Boysen G; Bordeerat N; Walker VE; Swenberg JA
Toxicol Sci; 2010 Jun; 115(2):322-9. PubMed ID: 20176624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]